Please login to the form below
Switzerland
This page shows the latest Switzerland news and features for those working in and with pharma, biotech and healthcare.
WHO and ESCEO partner to develop roadmap for bone health and ageing
Dr Jean-Yves Reginster, president of ESCEO, who signed the agreement at the WHO headquarters in Geneva, Switzerland, said: “With the ageing of the world’s populations, musculoskeletal disorders such as
Latest news
-
WHO to establish tuberculosis vaccine accelerator council
Announced by WHO director-general Dr Tedros Adhanom Ghebreyesus at a high-level panel on TB at the World Economic Forum in Switzerland, the new council is intended to bring together
-
Kinarus’ KIN001 shows strong antiviral activity against BA.2 and BA.5 Omicron subvariants
The primary endpoint of the study, which is actively recruiting in Switzerland and Germany, is the reduction in the severity and duration of COVID-19 symptoms.
-
MHRA approves LEO Pharma’s Adtralza for adolescent patients with atopic dermatitis
To date, tralokinumab is also approved for the treatment of adults with moderate-to-severe atopic dermatitis in Canada, the UAE and Switzerland.
-
Novavax’s COVID-19 vaccine receives MHRA approval for use as a booster
Nuvaxovid is also available for use as a booster in adults aged 18 years and older in the US, EU, Japan, Australia, New Zealand, Switzerland and Israel.
-
Merck to donate Sudan Ebola virus vaccine to International AIDS Vaccine Initiative
The Ervebo vaccine is approved in the UK, the EU, the US, Switzerland and ten countries in Africa as a single dose for adults 18 years and older, to protect against
More from news
Approximately 14 fully matching, plus 327 partially matching documents found.
Latest Intelligence
-
Creating the urgency and drive needed to tackle antimicrobial resistance
Two other doctors who are looking to make a difference in the space and affect policy are Eduardo García-Toledano in Spain and Haileyesus Getahun in Switzerland, both of whom discussed
-
Diversity in Pharma: The Impact of COVID-19 on DE&I
Meet the panel:. Andrés López Castaño, Vaccine Therapeutic Area Lead, Global LGBTQI+ ERG Lead, MSD Switzerland.
-
Rare genetic diseases – what’s in store for 2021?
Novartis HQ in Basel, Switzerland. Who would have predicted a complete worldwide shutdown in 2020?
-
Switzerland: a life sciences hub
Switzerland ranks first when it comes to international co-inventions, and third at R&D expenditure per capita. ... Inventions and patents. In 2019, Switzerland also filed a record number of patent applications per capita overall.
-
How COVID-19 is accelerating the threat of antimicrobial resistance
Potential long-term impact. An HCP in Switzerland shared her frustration that there is little discussion happening about AMR in the times of the COVID-19 pandemic, and called for her
More from intelligence
Approximately 1 fully matching, plus 43 partially matching documents found.
Latest appointments
-
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
UDG Healthcare company Ashfield Engage has announced the appointment of Serap Becker (pictured above) as its new head of patient solutions in the DACH region (Austria, Germany, and Switzerland).
-
David Eatwell joins Porterhouse Insights
Earlier in his career, he worked at Novartis in its headquarters in Switzerland, within the company’s combinatorial lead synthesis chemistry research team.
-
New hires at bluebird bio, BioNTech and Provention Bio
In her new role, Heffron will be based in Zug, Switzerland, where she will aid the launch of bluebird’s first commercial product – its gene therapy Zynteglo.
-
New hires at FibroGen, Saniona and Turbine
Prior to Sobi, Levin held commercial leadership roles of increasing strategic importance at Merck Serono across a number of countries, including the US, Sweden, Switzerland and Israel.
-
Health comms agency emotive hires new cell and gene therapy leader
scientific institutions across the globe, including Singapore, Switzerland, London, Belgium, theUS and Italy.
More from appointments
Approximately 1 fully matching, plus 60 partially matching documents found.
Latest from PMHub
-
The power of influence in transforming women’s health
Ageing and Estrogens. Frontiers of Hormone Research, Proceedings of the 1st International Workshop on Estrogen Therapy, Geneva, Switzerland, 1972. ... Volume 2. S. Karger; Basel, Switzerland: 1973. pp. 160–173.
-
Create, captivate and communicate: Cogent, a new full-service healthcare communications agency joins the AMICULUM® family
Hong Kong, Singapore, UAE, Switzerland, the UK and the USA.
-
Wedgewood Communications joins imc group to expand its presence in the US market
Waterland manages 8 billion in funds and has teams based in the UK, Ireland, France, the Netherlands, Belgium, Germany, Poland, Switzerland and Denmark, and operates across Europe.
-
AMICULUM® launches Cence, a new specialist publications agency
Hong Kong, Singapore, UAE, Switzerland, the UK and the USA.
-
Waterland-backed imc group progresses ambitious growth strategy with the addition of Indigo Medical
Waterland manages 8 billion in funds and has teams based in the United Kingdom, Ireland, France, Netherlands, Belgium, Germany, Poland, Switzerland, and Denmark, and operates across Europe.
More from PMHub
Approximately 1 fully matching, plus 28 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Origins - The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
